Provider

Adam Hutchinson, oVRcome founder and CEO, discusses reducing phobias using VR exposure therapy, how the company fills the gap in VR psychiatric care access for providers and patients, and its trial on combatting social anxiety with VR.

The behavioral health company's Engage platform will be available to existing commercial fully insured, self-funded members on an opt-in basis and via Sentara's Marketplace membership.

The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.

We're facing an average of two data breaches a day across the country, says Greg Garcia, executive director of the Health Sector Coordinating Council Cybersecurity Working Group. Still, we have the tools to respond to and mitigate the damage.

The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.

The company offers a marketplace for individuals seeking addiction and mental health treatment. It will use the funds to scale its workforce and expand its reach.

Dr. Eric Lieberman, CEO of CybersolutionsMD, discusses advising care organizations on ensuring collaborative decision-making in cybersecurity for patient safety - and the government’s role in helping organizations protect their technologies.  

This marks AITRICS's first foray into Southeast Asia, with applications for regulatory clearance in Indonesia and Malaysia underway.